Objectives

After participating in this educational activity, attendees should be able to:
1. Summarize the overall evidence for medication treatment of opioid use disorder.

2. Explain benefits of initiation of medication treatment in ED and inpatient settings.

3. Discuss at least three of the latest recommendations regarding the delivery of buprenorphine treatment.

Faculty

Ari Kriegsman, MD
Medical Director Addiction Medicine Consult Service   
Mercy Medical Center, Trinity Health of New England

None of the members of the faculty and planning committee for this educational event have commercial relationships with any entity producing, marketing, re-selling or distributing health care goods and services consumed by or used on patients.
 

Session date: 
03/05/2019 - 8:30am to 9:45am EST
Location: 
Baystate Medical Center
759 Chestnut Street
Springfield, MA 01199
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC Contact Hours
  • 1.00 APA American Psychological Association
    Baystate Health is approved by the American Psychological Association to sponsor continuing education for psychologists. Baystate Health maintains responsibility for this program and its content.
  • 1.00 BCIPE Instructional Hours
  • 1.00 NASW Smith CE Credits
    This program was approved for 1.00 Continuing Education Credits by Smith College School for Social Work and assigned authorization number in accordance with Continuing Education Regulation 258 CMR, Category I, in the Commonwealth of Massachusetts
  • 1.00 NBCC
    Baystate Health is an NBCC Approved Continuing Education Provider (ACEP™) and may offer NBCC approved clock hours for events that meet NBC requirements. The ACEP solely responsible for all aspects of the program.

Please login or register to take this course.